In This Article:
Morgan Stanley raised the firm’s price target on DocuSign (DOCU) to $97 from $62 and keeps an Equal Weight rating on the shares. Docusign is executing to its strategic plan with “several encouraging trends” driving outperformance in Q3 and stronger than expected Q4 billings guidance, the analyst tells investors. Fundamentally, metrics and commentary showed stabilization or improvement, but significant share outperformance and a stock in the mid-$90’s in the afterhours “suggests a bullish path ahead is well reflected in shares,” the analyst argues.
Pick the best stocks and maximize your portfolio:
-
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
-
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DOCU: